Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...

Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology and Research (A*STAR) have made strides in understanding the ...

Xanomeline/trospium chloride may help improve cognition in patients with acute schizophrenia and cognitive impairment, ...

Events like one held Thursday at Fayetteville Town Center can affect how challenges surrounding schizophrenia and mental ...

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers of the University of ...

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better ...

A number of first-in-disease, first-in-class and first-in-modality drugs approved last year have redefined therapeutic areas, ...